Exelixis
S&P 400
$56.12
-2.28%
Delayed · cached 15 min
Frequently asked questions
What sector does Exelixis belong to?
Exelixis operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of EXEL?
As of the latest available quote, EXEL traded at $56.12. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of EXEL?
Exelixis has a price-to-earnings (P/E) ratio of about 17.65. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of EXEL?
The market capitalisation of Exelixis is approximately $15.80B.
Is Exelixis profitable?
For its latest reported financial year, Exelixis recorded a net profit margin of about 33.73%.
Does EXEL pay a dividend?
Exelixis does not currently show a dividend yield in our data.
What is the return on equity (ROE) of EXEL?
Exelixis has a return on equity (ROE) of about 42.44%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of EXEL?
Over the past 52 weeks, EXEL has traded between a low of $33.76 and a high of $59.72.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.